Medically Reviewed By
Dr. Aditya Singh, MBBS, MD (Pharmacology)
Reg No: MCI-654321 • Verified Medical Reviewer
Kofarest-DX Linctus
(Chlorpheniramine Maleate (2mg/5ml) + Dextromethorphan Hydrobromide (10mg/5ml) + Menthol (1.5mg/5ml))
Uses, side effects, dosage information & price range
About this medicine
Kofarest-DX Linctus is a combination medicine used to treat dry cough. It thins mucus in the nose, windpipe and lungs, making it easier to cough out. It also provides relief from allergic symptoms like runny nose, watery eyes and throat irritation.Kofarest-DX Linctus is taken with or without food in
What are the side effects of Chlorpheniramine Maleate (2mg/5ml) + Dextromethorphan Hydrobromide (10mg/5ml) + Menthol (1.5mg/5ml) (Kofarest-DX Linctus)?
Not everyone experiences these side effects. Consult your doctor if any persist.
- Drowsiness
- Sleepiness
- Upset stomach
Common Brand Names for this Composition
The following popular commercial brand names contain Chlorpheniramine Maleate (2mg/5ml) + Dextromethorphan Hydrobromide (10mg/5ml) + Menthol (1.5mg/5ml) as their active ingredient composition:
Kofarest-DX Linctus
Centaur Pharmaceuticals Pvt Ltd
Common Substitutes & Alternatives
These medicines share the same salt composition or therapeutic category and can be used as substitutes under professional medical supervision.
Key Information
Salt / Composition
Chlorpheniramine Maleate (2mg/5ml) + Dextromethorphan Hydrobromide (10mg/5ml) + Menthol (1.5mg/5ml)
Category
Antitussives Without Codeine
Manufacturer
Centaur Pharmaceuticals Pvt Ltd
Price (MRP)
₹58.41
Medical Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice. Always consult your doctor or pharmacist before taking any medication. Prices are indicative and may vary. Do not start, stop, or change the dosage of any medicine without your doctor's approval.
Disclaimer:Content on this page is for informational purposes only. Do not consume prescription medication without a registered practitioner's direct oversight.